• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将医学证据转化为促进明智的医疗保健决策。

Translating medical evidence to promote informed health care decisions.

机构信息

RTI International, 3040 Cornwallis Road, Research Triangle Park, NC 27709, USA.

出版信息

Health Serv Res. 2011 Aug;46(4):1200-23. doi: 10.1111/j.1475-6773.2011.01248.x. Epub 2011 Feb 25.

DOI:10.1111/j.1475-6773.2011.01248.x
PMID:21352225
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3165184/
Abstract

OBJECTIVE

To examine the effects of a community-based intervention on decisions about prostate-specific antigen (PSA) screening using multiple measures of informed decision making (IDM).

DATA SOURCES/STUDY SETTING: Nonequivalent control group time series design collecting primary data in late 2004 and 2005.

STUDY DESIGN

We developed a multimodal intervention designed to convey the medical uncertainty about the benefits of PSA screening and early treatment and the limited predictive ability of both the PSA test and pathological specimens collected from prostate biopsy. We examined (1) patients' recognition that there is a decision to be made about PSA screening, (2) prostate cancer knowledge levels, (3) their preferred and actual levels of participation in decision making about screening at three points in time, and (4) screening decision.

DATA COLLECTION

Baseline data collection occurred in community-based organizations. These organizations served as recruiting sources and as sites for the intervention. We collected follow-up data by mail with telephone reminders.

PRINCIPAL FINDINGS

Our intervention was associated with greater recognition of the PSA test as a decision to be made, levels of knowledge, both preferred and actual levels of involvement in decision making, but did not have an impact on the screening decision.

CONCLUSIONS

Community-based interventions can influence key measures of IDM about PSA screening.

摘要

目的

使用多种知情决策(IDM)测量方法,研究基于社区的干预对前列腺特异性抗原(PSA)筛查决策的影响。

数据来源/研究设置:在 2004 年底和 2005 年收集原始数据的非等效对照组时间序列设计。

研究设计

我们开发了一种多模式干预措施,旨在传达关于 PSA 筛查和早期治疗益处的医学不确定性,以及 PSA 测试和前列腺活检中收集的病理标本的预测能力均有限。我们检查了(1)患者对 PSA 筛查做出决策的认识,(2)前列腺癌知识水平,(3)他们在三个时间点对筛查做出决策的首选和实际参与程度,以及(4)筛查决策。

数据收集

基线数据收集在社区组织中进行。这些组织既是招募来源,也是干预的场所。我们通过邮件收集随访数据,并通过电话提醒。

主要发现

我们的干预措施与对 PSA 测试作为要做出的决策的认识、知识水平、参与决策的首选和实际程度都有所提高,但对筛查决策没有影响。

结论

基于社区的干预措施可以影响关于 PSA 筛查的知情决策的关键措施。

相似文献

1
Translating medical evidence to promote informed health care decisions.将医学证据转化为促进明智的医疗保健决策。
Health Serv Res. 2011 Aug;46(4):1200-23. doi: 10.1111/j.1475-6773.2011.01248.x. Epub 2011 Feb 25.
2
A community-based intervention to promote informed decision making for prostate cancer screening among Hispanic American men changed knowledge and role preferences: a cluster RCT.一项基于社区的干预措施,旨在促进西班牙裔美国男性对前列腺癌筛查的知情决策:一项群组 RCT 研究。
Patient Educ Couns. 2011 Aug;84(2):e44-51. doi: 10.1016/j.pec.2010.07.033. Epub 2011 Jan 14.
3
Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions?使用前列腺特异性抗原检测筛查前列腺癌:患者是否在做出明智的决策?
J Fam Pract. 1999 Sep;48(9):682-8.
4
Promoting prostate-specific antigen informed decision-making. Evaluating two community-level interventions.促进前列腺特异性抗原知情决策。评估两种社区层面的干预措施。
Am J Prev Med. 2008 Aug;35(2):87-94. doi: 10.1016/j.amepre.2008.04.016.
5
Behind Closed Doors: What Happens when Patients and Providers Talk about Prostate-Specific Antigen Screening?: Survey of the Effects of a Community-Based Intervention.闭门会议:医患讨论前列腺特异性抗原筛查时会发生什么?:一项基于社区的干预措施效果调查。
Patient. 2009 Sep 1;2(3):191-201. doi: 10.2165/11312730-000000000-00000.
6
Shared decision making for prostate cancer screening: the results of a combined analysis of two practice-based randomized controlled trials.基于实践的两项随机对照试验联合分析:前列腺癌筛查中共同决策的结果。
BMC Med Inform Decis Mak. 2012 Nov 13;12:130. doi: 10.1186/1472-6947-12-130.
7
Informed decision making and prostate specific antigen (PSA) testing for prostate cancer: a randomised controlled trial exploring the impact of a brief patient decision aid on men's knowledge, attitudes and intention to be tested.前列腺癌的知情决策与前列腺特异性抗原(PSA)检测:一项随机对照试验,探讨简短患者决策辅助工具对男性关于检测的知识、态度及意愿的影响。
Patient Educ Couns. 2006 Nov;63(3):367-79. doi: 10.1016/j.pec.2006.05.005. Epub 2006 Jul 27.
8
Deliberative democracy and cancer screening consent: a randomised control trial of the effect of a community jury on men's knowledge about and intentions to participate in PSA screening.协商民主与癌症筛查同意书:关于社区陪审团对男性前列腺特异性抗原筛查知识及参与意愿影响的随机对照试验
BMJ Open. 2014 Dec 24;4(12):e005691. doi: 10.1136/bmjopen-2014-005691.
9
Promoting informed prostate cancer screening decision-making for African American men in a community-based setting.在社区环境中促进非裔美国男性进行明智的前列腺癌筛查决策。
Cancer Causes Control. 2022 Apr;33(4):503-514. doi: 10.1007/s10552-021-01544-9. Epub 2022 Jan 29.
10
National evidence on the use of shared decision making in prostate-specific antigen screening.国家关于在前列腺特异性抗原筛查中使用共同决策的证据。
Ann Fam Med. 2013 Jul-Aug;11(4):306-14. doi: 10.1370/afm.1539.

引用本文的文献

1
Interventions for increasing the use of shared decision making by healthcare professionals.提高医疗保健专业人员共同决策使用率的干预措施。
Cochrane Database Syst Rev. 2018 Jul 19;7(7):CD006732. doi: 10.1002/14651858.CD006732.pub4.
2
Parent Preferences for Shared Decision-making in Acute Versus Chronic Illness.急性病与慢性病中家长对共同决策的偏好
Hosp Pediatr. 2017 Oct;7(10):602-609. doi: 10.1542/hpeds.2017-0049.
3
Establishing the infrastructure to conduct comparative effectiveness research toward the elimination of disparities: a community-based participatory research framework.建立基础设施以开展消除差异的比较效果研究:一个基于社区的参与性研究框架。
Health Promot Pract. 2013 Nov;14(6):893-900. doi: 10.1177/1524839913475451. Epub 2013 Feb 21.
4
Shared decision making for prostate cancer screening: the results of a combined analysis of two practice-based randomized controlled trials.基于实践的两项随机对照试验联合分析:前列腺癌筛查中共同决策的结果。
BMC Med Inform Decis Mak. 2012 Nov 13;12:130. doi: 10.1186/1472-6947-12-130.
5
Development of a fragile X syndrome (FXS) knowledge scale: towards a modified multidimensional measure of informed choice for FXS population carrier screening.脆性 X 综合征(FXS)知识量表的制定:为 FXS 人群携带者筛查制定一种经过改良的多维知情选择衡量方法。
Health Expect. 2015 Feb;18(1):69-80. doi: 10.1111/hex.12009. Epub 2012 Oct 15.

本文引用的文献

1
American Cancer Society guideline for the early detection of prostate cancer: update 2010.美国癌症协会前列腺癌早期检测指南:2010 年更新版。
CA Cancer J Clin. 2010 Mar-Apr;60(2):70-98. doi: 10.3322/caac.20066. Epub 2010 Mar 3.
2
Comments and response on the USPSTF recommendation on screening for breast cancer.关于美国预防服务工作组(USPSTF)乳腺癌筛查建议的评论与回应
Ann Intern Med. 2010 Apr 20;152(8):540; author reply 543-4. doi: 10.7326/0003-4819-152-8-201004200-00202. Epub 2010 Feb 15.
3
Decision aids for people facing health treatment or screening decisions.为面临医疗治疗或筛查决策的人群提供的决策辅助工具。
Cochrane Database Syst Rev. 2009 Jul 8(3):CD001431. doi: 10.1002/14651858.CD001431.pub2.
4
Communication message strategies for increasing knowledge about prostate cancer screening.提高前列腺癌筛查知识的沟通信息策略。
J Cancer Educ. 2009;24(3):238-43. doi: 10.1080/08858190902935498.
5
Mortality results from a randomized prostate-cancer screening trial.一项前列腺癌随机筛查试验的死亡率结果。
N Engl J Med. 2009 Mar 26;360(13):1310-9. doi: 10.1056/NEJMoa0810696. Epub 2009 Mar 18.
6
Promoting prostate-specific antigen informed decision-making. Evaluating two community-level interventions.促进前列腺特异性抗原知情决策。评估两种社区层面的干预措施。
Am J Prev Med. 2008 Aug;35(2):87-94. doi: 10.1016/j.amepre.2008.04.016.
7
Trials of decision aids for prostate cancer screening: a systematic review.前列腺癌筛查决策辅助工具的试验:一项系统评价。
Am J Prev Med. 2007 Nov;33(5):428-434. doi: 10.1016/j.amepre.2007.07.030.
8
Are physicians discussing prostate cancer screening with their patients and why or why not? A pilot study.医生是否在与患者讨论前列腺癌筛查?原因是什么或为什么不讨论?一项试点研究。
J Gen Intern Med. 2007 Jul;22(7):901-7. doi: 10.1007/s11606-007-0142-3.
9
The contingency of patient preferences for involvement in health decision making.患者参与健康决策偏好的偶然性。
Health Care Manage Rev. 2007 Jan-Mar;32(1):30-6. doi: 10.1097/00004010-200701000-00005.
10
The meaning of patient involvement and participation in health care consultations: a taxonomy.患者参与医疗保健咨询的意义:一种分类法。
Soc Sci Med. 2007 Mar;64(6):1297-310. doi: 10.1016/j.socscimed.2006.11.002. Epub 2006 Dec 13.